Cargando…
Neuromyelitis optica spectrum disorder: Patient experience and quality of life
OBJECTIVE: To gain insights into NMOSD disease impact, which may negatively affect QoL of patients, their families, and social network. METHODS: The current study used validated instruments to assess physical, emotional, and socioeconomic burden of NMOSD on QoL among 193 patients. RESULTS: A majorit...
Autores principales: | Beekman, Janine, Keisler, Aysha, Pedraza, Omar, Haramura, Masayuki, Gianella-Borradori, Athos, Katz, Eliezer, Ratchford, John N., Barron, Gerard, Cook, Lawrence J., Behne, Jacinta M., Blaschke, Terrence F., Smith, Terry J., Yeaman, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624099/ https://www.ncbi.nlm.nih.gov/pubmed/31355316 http://dx.doi.org/10.1212/NXI.0000000000000580 |
Ejemplares similares
-
Restoring immune tolerance in neuromyelitis optica: Part I
por: Steinman, Larry, et al.
Publicado: (2016) -
Restoring immune tolerance in neuromyelitis optica: Part II
por: Bar-Or, Amit, et al.
Publicado: (2016) -
Challenges and opportunities in designing clinical trials for neuromyelitis optica
por: Weinshenker, Brian G., et al.
Publicado: (2015) -
Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
por: Cree, Bruce AC, et al.
Publicado: (2015) -
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
por: Fujihara, Kazuo, et al.
Publicado: (2020)